Metformin Protects Radiation-Induced Early Brain Injury by Reducing Inflammation and DNA Damage

Radiation-induced brain injury (RIBI) is one of the most common and fatal complications of cranial radiation therapy (CRT); however, no effective intervention is available currently. Metformin has been reported to have anti-RIBI activity as a first-line anti-diabetic drug. However, the mechanism of...

Full description

Bibliographic Details
Main Authors: Jiabao Xiang, Yiming Lu, Cheng Quan, Yan Gao, Gangqiao Zhou
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Brain Sciences
Subjects:
Online Access:https://www.mdpi.com/2076-3425/13/4/645
_version_ 1797606168699338752
author Jiabao Xiang
Yiming Lu
Cheng Quan
Yan Gao
Gangqiao Zhou
author_facet Jiabao Xiang
Yiming Lu
Cheng Quan
Yan Gao
Gangqiao Zhou
author_sort Jiabao Xiang
collection DOAJ
description Radiation-induced brain injury (RIBI) is one of the most common and fatal complications of cranial radiation therapy (CRT); however, no effective intervention is available currently. Metformin has been reported to have anti-RIBI activity as a first-line anti-diabetic drug. However, the mechanism of action is unclear. An RIBI mice model and an in vitro cell model under 30 and 10 Gy <sup>60</sup>Co γ-rays exposure were established to investigate the mechanism of metformin in RIBI. The results showed that pre-treatment with metformin protects hippocampal neurogenesis in the brain of mice and improves learning and memory ability after irradiation. Further investigations revealed that metformin pretreatment reduces inflammation and decreases DNA damage in the in vitro BV2 cell line. In addition, we observed that metformin inhibits the activation of <i>IκB</i> and <i>IRF-3</i>, which are downstream components of the cGAS-STING pathway. These findings suggest that metformin might protect the brain from RIBI, at least partly, through the cGAS pathway, making it a potential therapeutic drug for RIBI.
first_indexed 2024-03-11T05:11:28Z
format Article
id doaj.art-d8bf4229be6b4020b1d2ef8e90fabd81
institution Directory Open Access Journal
issn 2076-3425
language English
last_indexed 2024-03-11T05:11:28Z
publishDate 2023-04-01
publisher MDPI AG
record_format Article
series Brain Sciences
spelling doaj.art-d8bf4229be6b4020b1d2ef8e90fabd812023-11-17T18:33:05ZengMDPI AGBrain Sciences2076-34252023-04-0113464510.3390/brainsci13040645Metformin Protects Radiation-Induced Early Brain Injury by Reducing Inflammation and DNA DamageJiabao Xiang0Yiming Lu1Cheng Quan2Yan Gao3Gangqiao Zhou4Graduate Collaborative Training Base of Academy of Military Sciences, Hengyang Medical School, University of South China, Hengyang 421001, ChinaDepartment of Genetics & Integrative Omics, State Key Laboratory of Proteomics, National Center for Protein Sciences, Beijing Institute of Radiation Medicine, Beijing 100850, ChinaDepartment of Genetics & Integrative Omics, State Key Laboratory of Proteomics, National Center for Protein Sciences, Beijing Institute of Radiation Medicine, Beijing 100850, ChinaCenter of Cognition and Brain Science, Beijing Institute of Basic Medical Sciences, Beijing 100850, ChinaGraduate Collaborative Training Base of Academy of Military Sciences, Hengyang Medical School, University of South China, Hengyang 421001, ChinaRadiation-induced brain injury (RIBI) is one of the most common and fatal complications of cranial radiation therapy (CRT); however, no effective intervention is available currently. Metformin has been reported to have anti-RIBI activity as a first-line anti-diabetic drug. However, the mechanism of action is unclear. An RIBI mice model and an in vitro cell model under 30 and 10 Gy <sup>60</sup>Co γ-rays exposure were established to investigate the mechanism of metformin in RIBI. The results showed that pre-treatment with metformin protects hippocampal neurogenesis in the brain of mice and improves learning and memory ability after irradiation. Further investigations revealed that metformin pretreatment reduces inflammation and decreases DNA damage in the in vitro BV2 cell line. In addition, we observed that metformin inhibits the activation of <i>IκB</i> and <i>IRF-3</i>, which are downstream components of the cGAS-STING pathway. These findings suggest that metformin might protect the brain from RIBI, at least partly, through the cGAS pathway, making it a potential therapeutic drug for RIBI.https://www.mdpi.com/2076-3425/13/4/645metforminradiationradiation-induced brain injury
spellingShingle Jiabao Xiang
Yiming Lu
Cheng Quan
Yan Gao
Gangqiao Zhou
Metformin Protects Radiation-Induced Early Brain Injury by Reducing Inflammation and DNA Damage
Brain Sciences
metformin
radiation
radiation-induced brain injury
title Metformin Protects Radiation-Induced Early Brain Injury by Reducing Inflammation and DNA Damage
title_full Metformin Protects Radiation-Induced Early Brain Injury by Reducing Inflammation and DNA Damage
title_fullStr Metformin Protects Radiation-Induced Early Brain Injury by Reducing Inflammation and DNA Damage
title_full_unstemmed Metformin Protects Radiation-Induced Early Brain Injury by Reducing Inflammation and DNA Damage
title_short Metformin Protects Radiation-Induced Early Brain Injury by Reducing Inflammation and DNA Damage
title_sort metformin protects radiation induced early brain injury by reducing inflammation and dna damage
topic metformin
radiation
radiation-induced brain injury
url https://www.mdpi.com/2076-3425/13/4/645
work_keys_str_mv AT jiabaoxiang metforminprotectsradiationinducedearlybraininjurybyreducinginflammationanddnadamage
AT yiminglu metforminprotectsradiationinducedearlybraininjurybyreducinginflammationanddnadamage
AT chengquan metforminprotectsradiationinducedearlybraininjurybyreducinginflammationanddnadamage
AT yangao metforminprotectsradiationinducedearlybraininjurybyreducinginflammationanddnadamage
AT gangqiaozhou metforminprotectsradiationinducedearlybraininjurybyreducinginflammationanddnadamage